Effectiveness of M-Test for oxaliplatin-induced peripheral neuropathy

Effectiveness of M-Test for oxaliplatin-induced peripheral neuropathy - The single-group study on the effectiveness of M-Test to peripheral neuropathy caused by oxaliplatin for colorectal cancer patient

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020533

Enrollment

Registered

2016-01-12

Start date

2016-01-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

We intervene from Feb.2015 to Mar. 2017. A micro cone is applied to the outpatient with Grade 1 and over of oxaliplatin-induced CIPN. It is attached on a valid acupuncture point of the surface where p

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who gives permission. The person without cognitive problems, without conversation problems and can sit without problems. The person who agreed to this study.

Exclusion criteria

Exclusion criteria: We exclude the following patients those with metabolic diseases, toxic diseases, hereditary neuropathy and autoimmune diseases. The person who a lead principal investigator judged to be inappropriate as a subject.

Design outcomes

Primary

Measure	Time frame
Using valid acupuncture point to stimulate the skin's surface with the micro cone, we assess subjective symptoms of peripheral neuropathy before and after. 2 or 3 weeks after intervention	—

Countries

Japan

Contacts

Public ContactShoko Oku

University of Miyazaki school of nursing faculty of medicine

oku0215@med.miyazaki-u.ac.jp0985-85-9826

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026